This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
AngioDynamics (ANGO) Beats Q2 Earnings, Lifts 2017 View
by Zacks Equity Research
AngioDynamics Inc. (ANGO) reported adjusted earnings of 19 cents per share in the second quarter of fiscal 2017 beating the Zacks Consensus Estimate by 3 cents.
Cerner Extends HNM Partnership with University of Missouri
by Zacks Equity Research
Cerner Corporation (CERN) and the University of Missouri Health Care announced that they have inked an agreement to extend their partnership.
Alere Forensic Toxicology Division Gets ABFT Accreditation
by Zacks Equity Research
Alere Inc. (ALR), a leading player in rapid diagnostic tests, announced that its forensic toxicology division has received accreditation from the American Board of Forensic Toxicology.
Luminex (LMNX) Gets FDA Clearance for ARIES GBS Assay
by Zacks Equity Research
Luminex Corporation (LMNX) announced that it has received FDA clearance for the ARIES Group B Streptococcus Assay for antepartum detection of GBS colonization.
Mazor Robotics (MZOR) Receives 21 System Orders in Q4
by Zacks Equity Research
Israel-based developer of robotic technology and products, Mazor Robotics Ltd. (MZOR), recently announced the receipt of 21 surgical guidance system orders in fourth-quarter 2016.
Cerner Hurt by Low System Sales and Intense Competition
by Zacks Equity Research
On Jan 3, we issued an updated research report on North Kansas City, MO-based Cerner Corporation (CERN).
Natus Medical Closes GN Otometrics Business Acquisition
by Zacks Equity Research
Natus Medical Incorporated (BABY) announced the purchase of GN Otometrics from Denmark-based GN Store Nord.
Patterson Companies Hurt by Competition & Integration Risks
by Zacks Equity Research
On Jan 3, we issued an updated research report on St. Paul, MN-based Patterson Companies Inc. (PDCO), a leading distributor and seller of dental and animal health products.
Top Ranked Momentum Stocks to Buy for December 12th
by Zacks Equity Research
Here are four stocks with Zacks Rank #1 (Strong Buy) and strong momentum characteristics for investors to consider today, December 12th:
Top Ranked Momentum Stocks to Buy for December 8th
by Zacks Equity Research
Here are four stocks with Zacks Rank #1 (Strong Buy) and strong momentum characteristics for investors to consider today, December 8th:
MedTech Sails Through Macro Woes: Stocks in Focus
by Zacks Equity Research
Mergers & acquisitions, emerging market expansion, positive demographic trends and new product innovation are the vital forces behind the continued uptrend in the sector's performance.
Top Ranked Momentum Stocks to Buy for November 30th
by Zacks Equity Research
Here are four stocks with Zacks Rank #1 (Strong Buy) and strong momentum characteristics for investors to consider today, November 30th:
Top Ranked Momentum Stocks to Buy for November 29th
by Zacks Equity Research
Here are four stocks with Zacks Rank #1 (Strong Buy) and strong momentum characteristics for investors to consider today, November 29th:
New Strong Buy Stocks for November 14th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday